The IPO Buzz: Biopharma’s Back in Play
Just one IPO is in the wings this week – and it hails from the biopharma sector. This isn’t a coincidence. Any time an industrial sector outperforms the broad U.S. stock market, it can catch the investor’s eagle eye. This is what has happened since the three major U.S. stock indexes bottomed out on March […]
April 5, 2020 Read More